中文 EN
聯絡我們 聯絡我們

TRAINING COURSES

培訓課程

AI藥物發展

AI藥物發展

課程上課地點

課程報名日 2026-05-13 ~ 2026-06-01

課程開始與結束日 2026-06-05 14:00 ~ 2026-06-05 16:00

上課講師 顧德諮詢有限公司/顧曼芹總經理

◇ COURSE SYLLABUS
  1. 以終為始的藥物發展策略
  2. AI藥物發展概念
  3. 未來發展趨勢
◇ INSTRUCTOR﹍ DR. MANNCHING SHERRY KU


◇ POSITION﹍ GM OF KUDER CONSULTING INC.


◇ EDUCATION
 
  • 9/78-9/83 Ph.D. in Pharmaceutics & Pharmaceutical Chemistry, The Ohio State University - GPA 3.88. Ph.D. Thesis on ADME including metabolite synthesis and C14 tissue distribution of Anticancer NCI contact Nucleosides under Professor Lou Malspeis.
  • in Pharmacy, B.S.9/74-6/78 National Taiwan University

◇ EXPERIENCE
 
  • Chairman of Board and Chief Executive Officer (CEO), Savior Lifetec Corp.
  • Founding President and Board member of Ruenhuei Biopharmaceuticals, Inc.
  • Founding President/CSO/Board member, TWi Biotech and TWi Pharma Inc.
  • Pfizer Co, Pearl River, NY 10965 (previously Wyeth Research/American Cyanamid/Lederle)
  • Vice Chairman, New Jersey Pharmaceutical Discussion Group
  • Member of the Executive Yuan Biotechnology Industry Strategy Advisory Committee (BTC)
  • In the 29-year tenure, she was promoted through the achievements: Developed more than 170 new clinical drugs, IND clinical research applications for 85 innovative new compounds and drugs, Successfully developed 9 marketed drugs, ect..

FEEDBACK FORM 課程回饋單

課程上課地點

課程報名日 2026-05-13 ~ 2026-06-01

課程開始與結束日 2026-06-05 14:00 ~ 2026-06-05 16:00

上課講師 顧德諮詢有限公司/顧曼芹總經理

本項回饋單共分為三個部分,包括課程滿意度回饋、學習測驗及心得回饋。請於課後填寫完成,並於欄位上填寫您的個人聯絡資料,感謝您的配合。

課程滿意度調查 (課程及講師評分)
課程內容

極差

尚可

極佳

學習目標說明清楚

學習內容對團隊有幫助

學習內容條理分明

例子、問答、個案研討有助學習

每個段落有充分時間完成學習目標

講師授課

極差

尚可

極佳

課程中準備充足

具備足夠主題專業知識

溝通技巧

內容介紹有組織、有計畫

鼓勵學員參與

引導課程滿足我的需求

提供學員積極的回饋

課程回饋心得